Literature DB >> 11744734

Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene. Its possible role in the Warburg effect.

Alexander Minchenko1, Irene Leshchinsky, Irina Opentanova, Nianli Sang, Vickram Srinivas, Valerie Armstead, Jaime Caro.   

Abstract

One of the key mediators of the hypoxic response in animal cells is the hypoxia-inducible transcription factor-1 (HIF-1) complex, in which the alpha-subunit is highly susceptible to oxygen-dependent degradation. The hypoxic response is manifested in many pathophysiological processes such as tumor growth and metastasis. During hypoxia, cells shift to a primarily glycolytic metabolic mode for their energetic needs. This is also manifested in the HIF-1-dependent up-regulation of many glycolytic genes. Paradoxically, tumor cells growing under conditions of normal oxygen tension also show elevated glycolytic rates that correlate with the increased expression of glycolytic enzymes and glucose transporters (the Warburg effect). A key regulator of glycolytic flux is the relatively recently discovered fructose-2,6-bisphosphate (F-2,6-P2), an allosteric activator of 6-phosphofructo-1-kinase (PFK-1). Steady state levels of F-2,6-P2 are maintained by the bifunctional enzyme PFK-2/F2,6-Bpase, which has both kinase and phosphatase activities. Herein, we show that one isozyme, PFKFB3, is highly induced by hypoxia and the hypoxia mimics cobalt and desferrioxamine. This induction could be replicated by the use of an inhibitor of the prolyl hydroxylase enzymes responsible for the von Hippel Lindau (VHL)-dependent destabilization and tagging of HIF-1 alpha. The absolute dependence of the PFKFB3 gene on HIF-1 was confirmed by its overexpression in VHL-deficient cells and by the lack of hypoxic induction in mouse embryonic fibroblasts conditionally nullizygous for HIF-1 alpha.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11744734      PMCID: PMC4518871          DOI: 10.1074/jbc.M110978200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

Review 1.  HIF-1 and human disease: one highly involved factor.

Authors:  G L Semenza
Journal:  Genes Dev       Date:  2000-08-15       Impact factor: 11.361

2.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

3.  Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway.

Authors:  P J Kallio; W J Wilson; S O'Brien; Y Makino; L Poellinger
Journal:  J Biol Chem       Date:  1999-03-05       Impact factor: 5.157

4.  Regulation of hypoxia-inducible factor is preserved in the absence of a functioning mitochondrial respiratory chain.

Authors:  E C Vaux; E Metzen; K M Yeates; P J Ratcliffe
Journal:  Blood       Date:  2001-07-15       Impact factor: 22.113

5.  The human ubiquitous 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene (PFKFB3): promoter characterization and genomic structure.

Authors:  A Navarro-Sabaté; A Manzano; L Riera; J L Rosa; F Ventura; R Bartrons
Journal:  Gene       Date:  2001-02-07       Impact factor: 3.688

6.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

Review 7.  6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase: a metabolic signaling enzyme.

Authors:  S J Pilkis; T H Claus; I J Kurland; A J Lange
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

8.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

9.  Sequence and structure of the human 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase heart isoform gene (PFKFB2).

Authors:  D Heine-Suñer; M A Díaz-Guillén; A J Lange; S Rodríguez de Córdoba
Journal:  Eur J Biochem       Date:  1998-05-15

10.  Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1.

Authors:  G L Semenza; B H Jiang; S W Leung; R Passantino; J P Concordet; P Maire; A Giallongo
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

View more
  101 in total

Review 1.  6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis.

Authors:  Mark H Rider; Luc Bertrand; Didier Vertommen; Paul A Michels; Guy G Rousseau; Louis Hue
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

Review 2.  Physiological and pathological responses to hypoxia.

Authors:  Carine Michiels
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

3.  Whole genome expression profile in neuroblastoma cells exposed to 1-methyl-4-phenylpyridine.

Authors:  E Mazzio; K F A Soliman
Journal:  Neurotoxicology       Date:  2012-07-07       Impact factor: 4.294

Review 4.  Targeting lactate metabolism for cancer therapeutics.

Authors:  Joanne R Doherty; John L Cleveland
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

5.  Molecular basis of the fructose-2,6-bisphosphatase reaction of PFKFB3: transition state and the C-terminal function.

Authors:  Michael C Cavalier; Song-Gun Kim; David Neau; Yong-Hwan Lee
Journal:  Proteins       Date:  2012-01-31

Review 6.  Hypoxia-inducible factors and their roles in energy metabolism.

Authors:  Nobuhito Goda; Mai Kanai
Journal:  Int J Hematol       Date:  2012-04-26       Impact factor: 2.490

Review 7.  Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?

Authors:  Nissim Hay
Journal:  Nat Rev Cancer       Date:  2016-09-16       Impact factor: 60.716

Review 8.  Steroid receptor coactivators as therapeutic targets in the female reproductive system.

Authors:  Maria M Szwarc; John P Lydon; Bert W O'Malley
Journal:  J Steroid Biochem Mol Biol       Date:  2015-07-04       Impact factor: 4.292

Review 9.  Endothelial cell metabolism in health and disease: impact of hypoxia.

Authors:  Brian W Wong; Elke Marsch; Lucas Treps; Myriam Baes; Peter Carmeliet
Journal:  EMBO J       Date:  2017-06-21       Impact factor: 11.598

10.  Hydrogen sulfide increases hypoxia-inducible factor-1 activity independently of von Hippel-Lindau tumor suppressor-1 in C. elegans.

Authors:  Mark W Budde; Mark B Roth
Journal:  Mol Biol Cell       Date:  2009-11-04       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.